Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium tuberculosis | Possible penicillin-binding protein | Get druggable targets OG5_149948 | All targets in OG5_149948 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | phospholipase D, putative | 0.3295 | 1 | 1 |
Echinococcus granulosus | phospholipase D | 0.2911 | 0.8726 | 0.8562 |
Chlamydia trachomatis | phospholipase D endonuclease family protein | 0.0528 | 0.0828 | 0.5 |
Onchocerca volvulus | Putative phospholipase D | 0.0622 | 0.1139 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0622 | 0.1139 | 0.042 |
Trypanosoma cruzi | cardiolipin synthetase, putative | 0.1149 | 0.2888 | 0.5 |
Chlamydia trachomatis | phospholipase D endonuclease family protein | 0.0528 | 0.0828 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.2146 | 0.6191 | 0.7225 |
Chlamydia trachomatis | phospholipase D superfamily protein | 0.0528 | 0.0828 | 0.5 |
Brugia malayi | Phospholipase D. Active site motif family protein | 0.1149 | 0.2888 | 0.2246 |
Plasmodium vivax | phosphatidylglycerophosphate synthase, putative | 0.0528 | 0.0828 | 0.5 |
Echinococcus multilocularis | phospholipase D | 0.2911 | 0.8726 | 0.8562 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0278 | 0 | 0.5 |
Chlamydia trachomatis | phospholipase D endonuclease family protein | 0.0528 | 0.0828 | 0.5 |
Entamoeba histolytica | phospholipase D, putative | 0.3295 | 1 | 1 |
Chlamydia trachomatis | phospholipase D endonuclease family protein | 0.0528 | 0.0828 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | cardiolipin synthase | 0.0528 | 0.0828 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.2146 | 0.6191 | 0.7225 |
Loa Loa (eye worm) | phospholipase D | 0.0622 | 0.1139 | 0.042 |
Echinococcus multilocularis | phospholipase D1 | 0.3295 | 1 | 1 |
Toxoplasma gondii | phospholipase D active site domain-containing protein | 0.1149 | 0.2888 | 0.5 |
Echinococcus granulosus | phospholipase D1 | 0.3295 | 1 | 1 |
Chlamydia trachomatis | phospholipase D superfamily protein | 0.0528 | 0.0828 | 0.5 |
Trypanosoma brucei | cardiolipin synthetase | 0.1149 | 0.2888 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.2767 | 0.8252 | 1 |
Trypanosoma brucei | cardiolipin synthetase, putative | 0.1149 | 0.2888 | 1 |
Plasmodium falciparum | mitochondrial cardiolipin synthase, putative | 0.0528 | 0.0828 | 0.5 |
Leishmania major | phosphatidylglycerophosphate synthase, putative | 0.0622 | 0.1139 | 1 |
Brugia malayi | Phospholipase D. Active site motif family protein | 0.0622 | 0.1139 | 0.034 |
Plasmodium falciparum | phosphatidylglycerophosphate synthase | 0.0528 | 0.0828 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.2767 | 0.8252 | 1 |
Plasmodium vivax | cardiolipin synthetase, putative | 0.0528 | 0.0828 | 0.5 |
Trypanosoma cruzi | cardiolipin synthetase, putative | 0.1149 | 0.2888 | 0.5 |
Schistosoma mansoni | phospholipase D | 0.3295 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 4.6109 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 5.6234 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 5.8048 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.